s6y
Company name or ticker
Search
Fulcrum Therapeutics, Inc.
4
Gould Robert J: Statement of changes in beneficial ownership of securities
Filed
Friday, January 13, 2023
Period
Jan 13, 2023
Accession number
0000899243-23-001803
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header